- Travere Therapeutics (TVTX, Financial) to announce Q1 2025 financial results on May 1, 2025.
- The company will host a conference call and webcast at 4:30 p.m. ET the same day.
- An archived version of the call will remain available for 30 days on Travere’s website.
Travere Therapeutics, Inc. (TVTX) has scheduled the release of its first quarter 2025 financial results for Thursday, May 1, 2025, following the closing of U.S. financial markets. The announcement will be accompanied by a conference call and webcast, aimed at discussing the financial outcomes and providing a broader business update.
The conference call is set to take place at 4:30 p.m. ET. Interested parties can access the webcast and dial-in information via the Investor page of Travere’s official website at https://ir.travere.com/events-and-presentations. For those unable to attend, an archived version of the call will be accessible online for a period of 30 days following the event.
Travere Therapeutics is a biopharmaceutical firm dedicated to developing therapies for rare diseases. The company is headquartered in San Diego, operates within the biotechnology industry, and its stock (TVTX, Financial) has a market cap of $1.32 billion. As of now, institutional ownership is at 109.23%, while insider ownership stands at 0.63%.
